Institutional investors purchased a net $8.4 million shares of NVO during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 9.52% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Major industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DESTINATION WEALTH MANAGEMENT Bought 133.4 Thousand shares of Novo Nordisk
DOUGLAS C. LANE & ASSOCIATES, IN... Bought 56.2 Thousand shares of Novo Nordisk
PATTEN & PATTEN, INC. Bought 15.5 Thousand shares of Novo Nordisk